AliveDx's MosaiQ® Platform Registered with FDA as Class II 510(k) Exempt, Enabling US Labs to Adopt High-Throughput Automated Immunoassay Testing
AliveDx
MosaiQ is a next-gen immunoassay platform delivering automated, multiplexed testing and actionable insights for complex conditions









